Archives des mots-clés : biomedical research

Potential predatory journals are colonizing the ICMJE recommendations list of followers

Posté le par

Authors : Dal-Ré R., Marušić A.

BACKGROUND

The International Committee of Medical Journal Editors (ICMJE) has expressed its concerns about predatory journals using the list of ICMJE Recommendations (ICMJE-R) followers to “gain the appearance of legitimacy.”

We assessed the presence of potential predatory journals on the ICMJE-R list and their adherence to ICMJE recommendations.

METHODS

A random sample of 350 journals from the estimated 3,100-3,200 biomedical journals listed as ICMJE-R followers was chosen. Data collected from the ICMJE and journal webpages in English were: adherence to six ICMJE-R policies/requirements, year of journal’s listing as ICMJE-R follower, discipline covered, publisher and its country of origin and existence of article processing charge.

Potential predatory journal was considered as one open access journal not being a member of a recognized listing in COPE, DOAJ, OASPA, AJOL and/or INASP.

RESULTS

Thirty-one percent of journals were considered to be potentially predatory; 94% of them were included in the ICMJE-R list in 2014-2018. Half were published in the United States and 62% were devoted to medicine.

Adherence to five of the six policies/requirements was infrequent, ranging from 51% (plagiarism) to 7% (trial registration). Seventy-two percent of journals mentioned a policy on authors’ conflicts of interest. Information on article processing charge was available for 76% journals and could not be found for 22%.

Authorship policy/ instructions were significantly more present in journals with publishers from India than from the USA (53% vs 30%; p = 0.047), with no differences in the other five policies.

CONCLUSION

Predatory journals should be deleted from the ICMJE-R list of followers to prevent misleading authors. ICMJE-R following journals need to be reevaluated with pre-defined published criteria.

URL : http://www.njmonline.nl/getpdf.php?id=2093

The impact of the open-access status on journal indices: a review of medical journals

Posté le par

Authors : Saif Aldeen AlRyalat, Mohammad Saleh, Mohammad Alaqraa, Alaa Alfukaha, Yara Alkayed, Maryann Abaza, Hadeel Abu Saa, Mohamed Alshamiry

Background

Over the past few decades, there has been an increase in the number of open access (OA) journals in almost all disciplines. This increase in OA journals was accompanied an increase in funding to support such movements.

Medical fields are among the highest funded fields, which further promoted its journals to move toward OA publishing. Here, we aim to compare OA and non-OA journals in terms of citation metrics and other indices.

Methods

We collected data on the included journals from Scopus Source List on 1st November 2018.  We filtered the list for medical journals only. For each journal, we extracted data regarding citation metrics, scholarly output, and wither the journal is OA or non-OA.

Results

On the 2017 Scopus list of journals, there was 5835 medical journals. Upon analyzing the difference between medical OA and non-OA journals, we found that OA journals had a significantly higher CiteScore (p< 0.001), percent cited (p< 0.001), and source normalized impact per paper (SNIP) (p< 0.001), whereas non-OA journals had higher scholarly output (p< 0.001).

Among the five largest journal publishers, Springer Nature published the highest frequency of OA articles (31.5%), while Wiley-Blackwell had the lowest frequency among its medical journals (4.4%).

Conclusion

Among medical journals, although non-OA journals still have higher output in terms of articles per year, OA journals have higher citation metrics.

URL : The impact of the open-access status on journal indices: a review of medical journals

DOI : https://doi.org/10.12688/f1000research.17979.1

Production and uptake of Open Access publications involving the private sector: the case of big pharma

Posté le par

Authors : Afredo Yegros-Yegros, Thed van Leeuwen

Over the last years Open Access has been ranked very high on science policy agenda’s both internationally as well as nationally. This resulted in many national mandates and international guidelines on OA publishing of scientific results.

One of the reasons OA has been pushed so strongly by science policy is found in the argument that what is financed publicly, should be publicly available. This argument, also known as the ‘tax payers argument’ is used to support and legitimize the push for open accessibility, not only of scientific publications, but also of the underlying research data, in order to guarantee the nonacademic sector, with lower degrees of accessibility to otherwise ‘behind-the-paywall’ information, access to outcomes of scientific research in the public sector.

In this study we will focus on the developments in the OA publishing in one particular institutional sector, the private sector. Business enterprises represent the main sector in terms of R&D investments.

According to Eurostat, in the year 2016 this sector represented 65% of the total R&D expenditures within the EU28. While objectives and incentives in the private sector might not always been aligned with the disclosure of research results in the open scientific literature, there is no doubt that this is the main actor when it comes to R&D performance.

Within the business sector, we will focus our study in the pharmaceutical sector, by selecting a number of large pharmaceutical companies. Pharmaceutical companies represent an interesting case of study, given that is it one of the most R&D intensive industries, while it si also known for its shift in R&D orientation, from an in-house focus in the development of R&D towards a model much more open and collaborative, with more interactions with academic partners and other companies.

Despite the importance of industrial R&D, until now it remains relatively understudied how private sector institutions which are active in R&D have embraced the OA movement, hence it remains relatively unknown how the private sector adapts to and can benefit from the new paradigm of open scholarship.

Our objective is to shed more light on the extent to which big pharma both has been publishing in OA and also has been benefiting from OA publications to build their own research.

URL : Production and uptake of Open Access publications involving the private sector: the case of big pharma

DOI : https://doi.org/10.31235/osf.io/zt6kc

Peer Review Bias: A Critical Review

Posté le par

Authors : Samir Haffar, Fateh Bazerbachi, M. Hassan Murad

Various types of bias and confounding have been described in the biomedical literature that can affect a study before, during, or after the intervention has been delivered.

The peer review process can also introduce bias. A compelling ethical and moral rationale necessitates improving the peer review process. A double-blind peer review system is supported on equipoise and fair-play principles.

Triple- and quadruple-blind systems have also been described but are not commonly used. The open peer review system introduces “Skin in the Game” heuristic principles for both authors and reviewers and has a small favorable effect on the quality of published reports.

In this exposition, we present, on the basis of a comprehensive literature search of PubMed from its inception until October 20, 2017, various possible mechanisms by which the peer review process can distort research results, and we discuss the evidence supporting different strategies that may mitigate this bias.

It is time to improve the quality, transparency, and accountability of the peer review system.

DOI : https://doi.org/10.1016/j.mayocp.2018.09.004

La recherche interventionnelle en santé : divers engagements dans la production collaborative de connaissances

Posté le par

Auteur/Author : Philippe Terral

En prenant pour terrain d’enquête un domaine de recherche interdisciplinaire et collaboratif émergeant dans le secteur de la santé, les Recherches Interventionnelles en Santé des Populations (RISP), cette contribution se propose de considérer les diverses formes d’engagement dans la production de ce type de connaissances.

Sont ainsi repérées quatre figures d’engagement (afficher, éprouver, persévérer et figer) qui rendent compte de modes de coordination plus ou moins maximalistes entre les acteurs de ces recherches, en lien avec différentes conceptions et pratiques de la diffusion et de la circulation des connaissances.

L’enquête se base sur trois grands types de données : des observations ethnographiques de RISP ainsi que des congrès et réunions de groupes d’experts produisant des réflexions sur ce type de recherches, des analyses d’écrits (articles, rapports, lettres d’information…) sur les RISP et des entretiens (12) avec les principaux experts du domaine.

URL : https://journals.openedition.org/rfsic/4581

Adapting data management education to support clinical research projects in an academic medical center

Posté le par

Author : Kevin B. Read

Background

Librarians and researchers alike have long identified research data management (RDM) training as a need in biomedical research. Despite the wealth of libraries offering RDM education to their communities, clinical research is an area that has not been targeted.

Clinical RDM (CRDM) is seen by its community as an essential part of the research process where established guidelines exist, yet educational initiatives in this area are unknown.

Case Presentation

Leveraging my academic library’s experience supporting CRDM through informationist grants and REDCap training in our medical center, I developed a 1.5 hour CRDM workshop.

This workshop was designed to use established CRDM guidelines in clinical research and address common questions asked by our community through the library’s existing data support program.

The workshop was offered to the entire medical center 4 times between November 2017 and July 2018. This case study describes the development, implementation, and evaluation of this workshop.

Conclusions

The 4 workshops were well attended and well received by the medical center community, with 99% stating that they would recommend the class to others and 98% stating that they would use what they learned in their work.

Attendees also articulated how they would implement the main competencies they learned from the workshop into their work.

For the library, the effort to support CRDM has led to the coordination of a larger institutional collaborative training series to educate researchers on best practices with data, as well as the formation of institution-wide policy groups to address researcher challenges with CRDM, data transfer, and data sharing.

URL : Adapting data management education to support clinical research projects in an academic medical center

DOI : https://dx.doi.org/10.5195%2Fjmla.2019.580

Open science precision medicine in Canada: Points to consider

Posté le par

Authors : Palmira Granados Moreno, Sarah E. Ali-Khan, Benjamin Capps, Timothy Caulfield, Damien Chalaud, Aled Edwards, E. Richard Gold, Vasiliki Rahimzadeh, Adrian Thorogood, Daniel Auld, Gabrielle Bertier, Felix Breden, Roxanne Caron, Priscilla M.D.G. César, Robert Cook-Deegan, Megan Doerr, Ross Duncan, Amalia M. Issa, Jerome Reichman, Jacques Simard, Derek So, Sandeep Vanamala, Yann Joly

Open science can significantly influence the development and translational process of precision medicine in Canada. Precision medicine presents a unique opportunity to improve disease prevention and healthcare, as well as to reduce health-related expenditures.

However, the development of precision medicine also brings about economic challenges, such as costly development, high failure rates, and reduced market size in comparison with the traditional blockbuster drug development model.

Open science, characterized by principles of open data sharing, fast dissemination of knowledge, cumulative research, and cooperation, presents a unique opportunity to address these economic challenges while also promoting the public good.

The Centre of Genomics and Policy at McGill University organized a stakeholders’ workshop in Montreal in March 2018. The workshop entitled “Could Open be the Yellow Brick Road to Precision Medicine?” provided a forum for stakeholders to share experiences and identify common objectives, challenges, and needs to be addressed to promote open science initiatives in precision medicine.

The rich presentations and exchanges that took place during the meeting resulted in this consensus paper containing key considerations for open science precision medicine in Canada.

Stakeholders would benefit from addressing these considerations as to promote a more coherent and dynamic open science ecosystem for precision medicine.

URL : Open science precision medicine in Canada: Points to consider

DOI : https://doi.org/10.1139/facets-2018-0034